Biotech startup aiming to turn the microbiome into predictive AI infrastructure.
Investment Rounds
Capital activity and funding progression
| Amount | Date | Round |
|---|---|---|
| $3.5 M | Mar, 2026 | pre-seed |
Industries
Frequently Asked Questions
Where is Outpost Bio located?
Outpost Bio is located in unknown, unknown.
What industries does Outpost Bio operate in?
Outpost Bio operates in the following industries: biotechnology, artificial intelligence, microbiome.
How much total funding has Outpost Bio raised?
Outpost Bio has raised a total of $3,500,000.
Who are the investors in Outpost Bio?
The investors in Outpost Bio are: Merantix Capital, Seedcamp, OpenSeed VC, Strategic Investors.
What is the primary mission of Outpost Bio?
Outpost Bio is a biotechnology company dedicated to developing innovative delivery technologies for RNA therapeutics, specifically targeting tissues outside of the liver.
How does the Outpost Bio platform improve RNA delivery?
The platform uses proprietary lipid nanoparticle technology to overcome biological barriers, allowing genetic medicines to reach specific organs and cells that were previously difficult to target.
Which tissues can Outpost Bio target with its technology?
The delivery system is engineered to reach a variety of extrahepatic tissues, including the lungs, heart, and skeletal muscle, providing new opportunities for treating systemic diseases.
What makes the Outpost Bio approach unique compared to other RNA companies?
While many RNA therapies are limited by their accumulation in the liver, this company focuses on precision delivery to other parts of the body to expand the therapeutic potential of genetic medicine.
What types of payloads can Outpost Bio deliver?
The delivery platform is designed to be versatile, supporting various types of RNA cargo such as mRNA to enable protein expression or gene regulation in specific target cells.